IMUNON enters CRADA with National Cancer Institute for IMNN-001
IMUNON said it entered a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute to advance clinical development of IMNN-001.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.